MOBII®
Loss of mobility due to wear and tear of the joints and bone function.
MOBII®
Nutraceutical developed to:
- reduce pain, discomfort, and inflammation;
- improve flexibility and joint mobility.
- reduce pain, discomfort, and inflammation;
- improve flexibility and joint mobility.
MOBII®
The use of undenatured type II collagen (UC-II™) as a base ingredient.
UC-II™ significantly decreases joint pain, discomfort and lack of mobility, outweighing the results of the combination of Glucosamine with Chondroitin.
UC-II™ significantly decreases joint pain, discomfort and lack of mobility, outweighing the results of the combination of Glucosamine with Chondroitin.
MOBII®
Reduction of the inflammation and deceleration of joint destruction.
Adults with flexibility problems and joint mobility.
Adults with flexibility problems and joint mobility.
MOBII®
Pack of 30 tablets with RapidTabs™ Technology
CNP: 7473397
CNP: 7473397
MOBII®
1 tablet per day.
If you find difficult to take the tablet it can be dissolved in water.
If you find difficult to take the tablet it can be dissolved in water.
MOBII®
Due to the lack of studies confirming the safety of use in case of pregnancy and breastfeeding, this supplement should not be used in these situations, unless indicated otherwise by your doctor or pharmacist.
The product should not be used in case of hypersensitivity, allergy and when there are known interactions between any ingredient of this formulation and other products.
The product should not be used in case of hypersensitivity, allergy and when there are known interactions between any ingredient of this formulation and other products.